Retroviral transduction of quiescent haematopoietic cells using a packaging cell line expressing the membrane-bound form of stem cell factor

Gene Therapy

Volumn 6, Issue 6, 1999, Pages 1084-1091

  Sehgal, A ^a   Weeratunge, N ^a   Casimir, C ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

galactosidase; Kit ligand; Retrovirus; Stem cells; Transduction

Indexed keywords

CD34 ANTIGEN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN; STEM CELL FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; RETROVIRUS; UMBILICAL CORD BLOOD;

ANIMALS; CELL DIVISION; GENETIC VECTORS; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; RETROVIRIDAE; STEM CELL FACTOR; TRANSDUCTION, GENETIC;

ANIMALIA; MURINAE; UNIDENTIFIED RETROVIRUS;

EID: 0033019205     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300932     Document Type: Article

References (38)

1. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
2. Roe T et al. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993; 12: 2099-2108.
3. Dunbar CE et al. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 1995; 85: 3048-3057.
4. Brenner MK et al. Gene transfer into human hemopoietic progenitor cells. Br Med Bull 1995; 51: 167-191.
5. Fairbanks LD et al. Biochemical and immunological status following gene therapy and PEG-ADA therapy for adenosine deaminase (ADA) deficiency. Adv Exp Med Biol 1994; 370: 391-394.
6. Kohn DB et al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med 1995; 1: 1017-1023.
7. Blaese RM et al. T lymphocyte-directed gene therapy for ADASCID: initial trial results after 4 years. Science 1995; 270: 475-480.
8. Bordignon C et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995; 270: 470-475.
9. Brenner MK et al. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 1993; 342: 1134-1137.
10. + cell populations and into TF-1 cells: future prospects in gene therapy. Hum Gene Ther 1994; 5: 1325-1333.
11. Clapp DW et al. Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells. Exp Hematol 1995; 23: 630-638.
12. Povey J et al. Enhanced retroviral transduction of 5FU-resistant human bone marrow (stem) cells using a genetically modified packaging cell line. Blood 1998; 92: 4080-4089.
13. Anderson DM et al. Alternate splicing of mRNAs encoding human mast cell growth factor and localization of the gene to chromosome 12q22-q24. Cell Growth Diff 1991; 2: 373-378.
14. Toksoz D et al. Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 1992; 89: 7350-7354.
15. Majumdar MK et al. Identification and mutation of primary and secondary proteolytic cleavage sites in murine stem cell factor cDNA yields biologically active, cell-associated protein. J Biol Chem 1994; 269: 1237-1242.
16. Kitamura T et al. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 1989; 140: 323-334.
17. Van Snick J. Interleukin-6: an overview. Ann Rev Immunol 1990; 8: 253-278.
18. Einerhand MP, Bakx TA, Valerio D. IL-6 production by retrovirus packaging cells and cultured bone marrow cells. Hum GeneTher 1991; 2: 301-306.
19. Kitamura T, Takaku F, Miyajima A. IL-1 up-regulates the expression of cytokine receptors on a factor-dependent human hemopoietic cell line, TF-1. Int Immunol 1991; 3: 571-577.
20. + cells in cord blood and in cytokine-mobilized blood. Br J Haematol 1996; 92: 255-262.
21. - cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753.
22. Hanley ME et al. Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer. Blood Cells 1994; 20: 539-543.
23. + cord blood hematopoietic progenitors in the presence and absence of growth factors. Blood Cells 1994; 20: 517-524.
24. Walsh CE et al. Transduction of CD34-enriched human peripheral and umbilical cord blood progenitors using a retroviral vector with the Fanconi anemia group C gene. J Invest Med 1995; 43: 379-385.
25. + cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood. Exp Hematol 1997; 25: 966-971.
26. Lu L et al. High efficiency retrovirus-mediated gene transduction into single isolated immature and replatable CD34(3+) hematopoietic stem/progenitor cells from human umbilical cord blood. J Exp Med 1993; 178: 2089-2096.
27. + cord blood cells under serum-free conditions. Hum Gene Ther 1997; 8: 1651-1658.
28. Bodine DM et al. Development of a high-litre retrovirus producer cell line capable of gene transfer into rhesus monkey haematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 3738-3742.
29. Hogge DE et al. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 1996; 88: 3765-3773.
30. Orlic D et al. Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. Blood 1993; 82: 762-770.
31. Berardi AC et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995; 267: 104-108.
32. Flanagan JG, Chan DC, Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 1991; 64: 1025-1035.
33. Huang EJ et al. Differential expression and processing of two cell associated forms of the kit-ligand: KL-1 and KL-2. Mol Biol Cell 1992; 3: 349-362.
34. Brannan CI et al. Steel-Dickie mutation encodes a c-kit ligand lacking transmembrane and cytoplasmic domains. Proc Natl Acad Sci USA 1991; 88: 4671-4674.
35. + bone marrow cells. Blood 1993; 82: 1975-1980.
36. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167: 400-406.
37. Callard RE, Kotowicz KT, Smith SH. Assays for human B cell responses to cytokines. In: Balkwill FR (ed). Cytokines: A Practical Approach. IRL Press: Oxford, 1995, pp 143-177.
38. Wilkinson D, Green J. In situ hybridization and three-dimensional reconstruction of serial sections. In: Rickwood D, Cockcroft DL (eds). Postimplantation Mouse Embryos: A Practical Approach. IRL Press: Oxford, 1990, pp 155-171.